Imbian Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -336.67%
(FY 2022)
- Ebitda -152.04%
(FY 2022)
- Net Worth -84.38%
(FY 2022)
- Total Assets -50.68%
(FY 2022)
About Imbian Healthcare India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhilash Pillai and Valiyakath Shahanad serve as directors at the Company.
- CIN/LLPIN
U74999DL2020PTC372337
- Company No.
372337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Imbian Healthcare India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhilash Pillai  | Director | 28-Oct-2020 | Current |
| Valiyakath Shahanad | Additional Director | 27-May-2022 | Current |
Financial Performance of Imbian Healthcare India.
Imbian Healthcare India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 336.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 84.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imbian Healthcare India?
Unlock access to Imbian Healthcare India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Tsea Global Technology Centre Private LimitedActive 2 years 2 months
Abhilash Pillai and Valiyakath Shahanad are mutual person
- Mecc Whitelotus Commodities Private LimitedActive 5 years 4 months
Valiyakath Shahanad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Imbian Healthcare India?
Imbian Healthcare India has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imbian Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imbian Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
